Browse by category

Adults with obesity and diabetes face higher health care utilisation costs with GLP-1s treatment compared with Bariatric metabolic surgery (BMS), excluding intervention costs, largely reflecting differences in early clinical trajectories, according to a study by researchers from Israel. These findings suggest that, among patients eligible for both interventions, BMS may confer combined clinical and economic advantages over long-term follow-up. The study was designed to compar

In patients with type 2 diabetes, Roux-en-Y gastric bypass and sleeve gastrectomy for weight loss may be effective for reducing long-term...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Only about half of US employers (52%) say they effectively manage healthcare costs, according to Gallagher's 2024 US Physical & Emotional...

A series of five studies presented at this year's European Congress of Obesity (ECO2022), in Maastricht, Netherlands, showed that around...